CAR-T Cell Therapy and Other Novel Therapies for Lymphoma
Podcast: Living with Lymphoma Home CAR-T Cell Therapy and Other Novel Therapies for Lymphoma In 2015, Robyn Stacy-Humphrie’s diffuse large B-Cell lymphoma (DLBCL) relapsed and she was faced with a tough decision – to follow the standard of care and receive a stem cell transplant, or opt for a new treatment called CAR-T cell therapy which at the time, was still in the A research study to test how well new medical approaches work in people. phase. Living with Lymphoma host, Victor Gonzalez, sat down with Robyn to discuss her decision to enter a A research study to test how well new medical approaches work in people. and receive CAR T and what her experience was receiving this cutting-edge therapy. They were joined by LRF Scientific Advisory Board member, Andrew M. Evens, DO, MSc, FACP (Rutgers Abnormal cell growth that cannot be controlled by the body's natural defenses. Cancerous cells can grow and eventually form tumors. Institute of New Jersey) who explained CAR-T cell therapy and its use for the treatment of certain types of lymphoma, as well as other novel therapies being used to treat relapsed/refractory DBCL. This episode was a special video event recorded for LRF’s YouTube channel.